InvestorsObserver
×
News Home

Is BioDelivery Sciences International, Inc. (BDSI) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?

Thursday, November 04, 2021 11:58 AM | InvestorsObserver Analysts

Mentioned in this article

Is BioDelivery Sciences International, Inc. (BDSI) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?

The 57 rating InvestorsObserver gives to BioDelivery Sciences International, Inc. (BDSI) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 94 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, BDSI’s 57 overall rating means the stock scores better than 57 percent of all stocks.

Overall Score - 57
BDSI has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on BDSI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With BioDelivery Sciences International, Inc. Stock Today?

BioDelivery Sciences International, Inc. (BDSI) stock is lower by -11.62% while the S&P 500 is up 0.17% as of 11:57 AM on Thursday, Nov 4. BDSI is lower by -$0.46 from the previous closing price of $3.96 on volume of 1,437,438 shares. Over the past year the S&P 500 is up 35.57% while BDSI is up 1.16%. BDSI earned $0.32 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 10.83. Click Here to get the full Stock Report for BioDelivery Sciences International, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App